Elfabrio receives vital MHRA authorisation
The therapy involves long-term enzyme replacement therapy for aduls with Fabry disease
Read More
Tag: authorisation
EC authorisation granted to kidney disease treatment Kinpeygo
The treatment was developed by Calliditas and will be marketed by Stada
Read More
Waylivra granted conditional marketing authorisation in Europe
The authorisation follows the positive opinion recommending approval provided by the Committee for Medicinal Products for Human Use (CHMP).
Read More
- NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats
- UCB reports superiority of bimekizumab in psoriatic arthritis study
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
